Oncocyte Corp Quarterly Current Ratio in % from Q3 2016 to Q3 2024

Taxonomy & unit
ratio: %
Description
The current ratio is a liquidity ratio that measures a company's ability to cover its short-term obligations with its current assets.
Summary
Oncocyte Corp quarterly Current Ratio history and growth rate from Q3 2016 to Q3 2024.
  • Oncocyte Corp Current Ratio for the quarter ending September 30, 2024 was 99.4 %, a 53.2% decline year-over-year.
Current Ratio, Quarterly (%)
Current Ratio, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date
Q3 2024 99.4 -113 -53.2% Sep 30, 2024
Q2 2024 142 -92.7 -39.6% Jun 30, 2024
Q1 2024 174 -87.1 -33.3% Mar 31, 2024
Q4 2023 196 -59.7 -23.3% Dec 31, 2023
Q3 2023 212 -59 -21.7% Sep 30, 2023
Q2 2023 234 -54.7 -18.9% Jun 30, 2023
Q1 2023 261 -2.05 -0.78% Mar 31, 2023
Q4 2022 256 -94.3 -26.9% Dec 31, 2022
Q3 2022 271 -55.9 -17.1% Sep 30, 2022
Q2 2022 289 +6.03 +2.13% Jun 30, 2022
Q1 2022 264 -34.2 -11.5% Mar 31, 2022
Q4 2021 350 +168 +92% Dec 31, 2021
Q3 2021 327 +63.4 +24% Sep 30, 2021
Q2 2021 283 -92.5 -24.6% Jun 30, 2021
Q1 2021 298 -235 -44.1% Mar 31, 2021
Q4 2020 183 -640 -77.8% Dec 31, 2020
Q3 2020 264 -411 -60.9% Sep 30, 2020
Q2 2020 376 -190 -33.6% Jun 30, 2020
Q1 2020 533 +125 +30.5% Mar 31, 2020
Q4 2019 823 +594 +260% Dec 31, 2019
Q3 2019 674 +433 +180% Sep 30, 2019
Q2 2019 565 +321 +132% Jun 30, 2019
Q1 2019 408 +173 +73.3% Mar 31, 2019
Q4 2018 228 -15.6 -6.4% Dec 31, 2018
Q3 2018 241 -28.3 -10.5% Sep 30, 2018
Q2 2018 244 -51.8 -17.5% Jun 30, 2018
Q1 2018 236 -68.7 -22.6% Mar 31, 2018
Q4 2017 244 -59.5 -19.6% Dec 31, 2017
Q3 2017 269 -69.8 -20.6% Sep 30, 2017
Q2 2017 296 Jun 30, 2017
Q1 2017 304 Mar 31, 2017
Q4 2016 304 Dec 31, 2016
Q3 2016 339 Sep 30, 2016
* An asterisk sign (*) next to the value indicates that the value is likely invalid.